vs
Side-by-side financial comparison of Agilent Technologies (A) and DuPont (DD). Click either name above to swap in a different company.
Agilent Technologies is the larger business by last-quarter revenue ($1.8B vs $1.7B, roughly 1.1× DuPont). Agilent Technologies runs the higher net margin — 17.0% vs 9.8%, a 7.2% gap on every dollar of revenue. On growth, Agilent Technologies posted the faster year-over-year revenue change (7.0% vs 4.0%). Over the past eight quarters, Agilent Technologies's revenue compounded faster (6.9% CAGR vs -27.2%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
DuPont de Nemours, Inc., commonly shortened to DuPont, is an American multinational chemical company first formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder.
A vs DD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $1.7B |
| Net Profit | $305.0M | $164.0M |
| Gross Margin | 52.6% | 35.8% |
| Operating Margin | 19.6% | — |
| Net Margin | 17.0% | 9.8% |
| Revenue YoY | 7.0% | 4.0% |
| Net Profit YoY | -4.1% | — |
| EPS (diluted) | $1.07 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $1.7B | ||
| Q4 25 | $1.9B | $-2.5B | ||
| Q3 25 | $1.7B | $3.1B | ||
| Q2 25 | $1.7B | $3.3B | ||
| Q1 25 | $1.7B | $3.1B | ||
| Q4 24 | $1.7B | $3.1B | ||
| Q3 24 | $1.6B | $3.2B | ||
| Q2 24 | $1.6B | $3.2B |
| Q1 26 | $305.0M | $164.0M | ||
| Q4 25 | $434.0M | $-126.0M | ||
| Q3 25 | $336.0M | $-123.0M | ||
| Q2 25 | $215.0M | $59.0M | ||
| Q1 25 | $318.0M | $-589.0M | ||
| Q4 24 | $351.0M | $-118.0M | ||
| Q3 24 | $282.0M | $454.0M | ||
| Q2 24 | $308.0M | $178.0M |
| Q1 26 | 52.6% | 35.8% | ||
| Q4 25 | 53.2% | — | ||
| Q3 25 | 51.1% | 38.9% | ||
| Q2 25 | 51.9% | 37.3% | ||
| Q1 25 | 53.5% | 37.4% | ||
| Q4 24 | 53.9% | 36.4% | ||
| Q3 24 | 54.2% | 37.4% | ||
| Q2 24 | 54.4% | 37.1% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | — | ||
| Q3 25 | 20.7% | 10.6% | ||
| Q2 25 | 18.0% | 9.4% | ||
| Q1 25 | 22.4% | -14.0% | ||
| Q4 24 | 24.0% | 1.4% | ||
| Q3 24 | 21.1% | 18.4% | ||
| Q2 24 | 23.1% | 9.3% |
| Q1 26 | 17.0% | 9.8% | ||
| Q4 25 | 23.3% | 4.9% | ||
| Q3 25 | 19.3% | -4.0% | ||
| Q2 25 | 12.9% | 1.8% | ||
| Q1 25 | 18.9% | -19.2% | ||
| Q4 24 | 20.6% | -3.8% | ||
| Q3 24 | 17.9% | 14.2% | ||
| Q2 24 | 19.6% | 5.6% |
| Q1 26 | $1.07 | $0.36 | ||
| Q4 25 | $1.53 | $-0.30 | ||
| Q3 25 | $1.18 | $-0.29 | ||
| Q2 25 | $0.75 | $0.14 | ||
| Q1 25 | $1.11 | $-1.41 | ||
| Q4 24 | $1.23 | $-0.28 | ||
| Q3 24 | $0.97 | $1.08 | ||
| Q2 24 | $1.05 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $710.0M |
| Total DebtLower is stronger | $3.0B | $3.2B |
| Stockholders' EquityBook value | $6.9B | $14.2B |
| Total Assets | $12.8B | $21.4B |
| Debt / EquityLower = less leverage | 0.44× | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $710.0M | ||
| Q4 25 | $1.8B | $715.0M | ||
| Q3 25 | $1.5B | $2.0B | ||
| Q2 25 | $1.5B | $1.8B | ||
| Q1 25 | $1.5B | $1.8B | ||
| Q4 24 | $1.3B | $1.9B | ||
| Q3 24 | $1.8B | $1.6B | ||
| Q2 24 | $1.7B | $1.5B |
| Q1 26 | $3.0B | $3.2B | ||
| Q4 25 | $3.0B | $3.1B | ||
| Q3 25 | $3.4B | $7.0B | ||
| Q2 25 | $3.3B | $5.3B | ||
| Q1 25 | $3.3B | $5.3B | ||
| Q4 24 | $3.3B | $5.3B | ||
| Q3 24 | $2.1B | $7.2B | ||
| Q2 24 | $2.1B | $7.2B |
| Q1 26 | $6.9B | $14.2B | ||
| Q4 25 | $6.7B | $13.9B | ||
| Q3 25 | $6.4B | $22.9B | ||
| Q2 25 | $6.1B | $23.1B | ||
| Q1 25 | $6.0B | $22.8B | ||
| Q4 24 | $5.9B | $23.4B | ||
| Q3 24 | $5.9B | $24.2B | ||
| Q2 24 | $6.2B | $23.3B |
| Q1 26 | $12.8B | $21.4B | ||
| Q4 25 | $12.7B | $21.6B | ||
| Q3 25 | $12.2B | $38.0B | ||
| Q2 25 | $12.2B | $36.6B | ||
| Q1 25 | $11.9B | $36.0B | ||
| Q4 24 | $11.8B | $36.6B | ||
| Q3 24 | $11.0B | $37.5B | ||
| Q2 24 | $10.9B | $36.6B |
| Q1 26 | 0.44× | 0.22× | ||
| Q4 25 | 0.45× | 0.23× | ||
| Q3 25 | 0.53× | 0.31× | ||
| Q2 25 | 0.55× | 0.23× | ||
| Q1 25 | 0.56× | 0.23× | ||
| Q4 24 | 0.57× | 0.23× | ||
| Q3 24 | 0.36× | 0.30× | ||
| Q2 24 | 0.34× | 0.31× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | — |
| FCF MarginFCF / Revenue | 9.7% | — |
| Capex IntensityCapex / Revenue | 5.2% | 6.1% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $-700.0M | ||
| Q3 25 | $362.0M | $497.0M | ||
| Q2 25 | $221.0M | $381.0M | ||
| Q1 25 | $431.0M | $382.0M | ||
| Q4 24 | $481.0M | $564.0M | ||
| Q3 24 | $452.0M | $737.0M | ||
| Q2 24 | $333.0M | $527.0M |
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $-850.0M | ||
| Q3 25 | $259.0M | $379.0M | ||
| Q2 25 | $107.0M | $265.0M | ||
| Q1 25 | $334.0M | $133.0M | ||
| Q4 24 | $388.0M | $403.0M | ||
| Q3 24 | $360.0M | $628.0M | ||
| Q2 24 | $230.0M | $425.0M |
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | 33.4% | ||
| Q3 25 | 14.9% | 12.3% | ||
| Q2 25 | 6.4% | 8.1% | ||
| Q1 25 | 19.9% | 4.3% | ||
| Q4 24 | 22.8% | 13.0% | ||
| Q3 24 | 22.8% | 19.7% | ||
| Q2 24 | 14.6% | 13.4% |
| Q1 26 | 5.2% | 6.1% | ||
| Q4 25 | 5.0% | -5.9% | ||
| Q3 25 | 5.9% | 3.8% | ||
| Q2 25 | 6.8% | 3.6% | ||
| Q1 25 | 5.8% | 8.1% | ||
| Q4 24 | 5.5% | 5.2% | ||
| Q3 24 | 5.8% | 3.4% | ||
| Q2 24 | 6.5% | 3.2% |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | 6.46× | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | 1.62× | ||
| Q2 24 | 1.08× | 2.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
DD
Segment breakdown not available.
